Print

Applied Biosystems (ABI) Announces Co-Development Agreement with Olink Bioscience  
10/1/2007 10:03:48 AM

FOSTER CITY, Calif.--(BUSINESS WIRE)--Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced that it has signed an exclusive license and collaboration agreement with Olink Bioscience to commercialize Olink’s proximity ligation assay (PLA) technology. Under the agreement, Applied Biosystems will co-develop the PLA technology for specific applications in the life science research market that include biomarker validation and characterization of complex biological processes. Financial terms of the agreement were not disclosed.
//-->